ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

BACKGROUND: ZNF217 is a candidate oncogene located at 20q13, a chromosomal region frequently amplified in breast cancers. The precise mechanisms involved in ZNF217 pro-survival function are currently unknown, and utmost importance is given to deciphering the role of ZNF217 in cancer therapy response...

Descripción completa

Detalles Bibliográficos
Autores principales: Thollet, Aurélie, Vendrell, Julie A, Payen, Léa, Ghayad, Sandra E, Ben Larbi, Sabrina, Grisard, Evelyne, Collins, Colin, Villedieu, Marie, Cohen, Pascale A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996367/
https://www.ncbi.nlm.nih.gov/pubmed/21059223
http://dx.doi.org/10.1186/1476-4598-9-291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996367/
https://www.ncbi.nlm.nih.gov/pubmed/21059223
http://dx.doi.org/10.1186/1476-4598-9-291

Ejemplares similares